Pantoprazole (Peploc, Peploc Otc, Pantoprazole PD)
Pantoprazole
Pharma Dynamics (Pty) Ltd
Registration
- Applicant
- Pharma Dynamics (Pty) Ltd
- Registrations
- 4
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Peploc 20 MG tablet EACH TABLET CONTAINS PANTOPRAZOLE SODIUM EQUIVALENT TO PANTOPRAZOLE 20,0 mg | 20 mgTablet | 42005642/11.4.3/0056 | Registered | Not determined | None |
| Peploc 40 MG EACH TABLET CONTAINS PANTOPRAZOLE SODIUM EQUIVALENT TO PANTOPRAZOLE 40,0 mg | 40 mg | 42005742/11.4.3/0057 | Registered | Not determined | None |
| Peploc otc tablet EACH TABLET CONTAINS PANTOPRAZOLE SODIUM EQUIVALENT TO PANTOPRAZOLE 20,0 mg | Tablet | 43034443/11.4.3/0344 | Registered | Not determined | None |
| Pantoprazole 40 MG PD EACH TABLET CONTAINS PANTOPRAZOLE SODIUM EQUIVALENT TO PANTOPRAZOLE 40,0 mg | 40 mgGastro-resistant tablet. | 43034543/11.4.3/0345Approved 5 November 2024 | Cancelled | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Pantoprazole sodium equivalent to pantoprazole
S4: Pantoprazole
- except when intended for the temporary short-term relief of heartburn and hyperacidity, subject to:
- a maximum daily dose of 20 milligrams (S2); and
- a maximum treatment period of 14 days. (S2)
Consolidated Schedules 06 July 2026, lines 7479 to 7482
S2: Pantoprazole
- when intended for the temporary short-term relief of heartburn and hyperacidity, subject to:
- maximum daily dose of 20 milligrams
- maximum treatment period of 14 days. (S4)
Consolidated Schedules 06 July 2026, lines 2482 to 2486
Pharmacological class: Other. (class 11.4.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
6-(Difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
Drag to rotate. Structure from PubChem CID 4679.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.